Singapore markets close in 6 hours 24 minutes

Fortrea Holdings Inc. (FTRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.22-0.49 (-1.98%)
At close: 04:00PM EDT
25.58 +1.36 (+5.62%)
After hours: 07:42PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close24.71
Open24.81
Bid24.20 x 200
Ask24.26 x 200
Day's range24.18 - 25.10
52-week range24.18 - 41.02
Volume1,170,805
Avg. volume1,148,782
Market cap2.208B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research

    Leverages real-world data, patient insights and a systematic process to design, operationalize and measure the effectiveness of diversity action plans in clinical trialsDURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity and inclusion (D&I) of participants in clinical trials. Fortrea’s D&I solution is designed to expand patie

  • GlobeNewswire

    Fortrea Appoints Machelle Sanders to Board of Directors

    Machelle Sanders Fortrea Appoints Machelle Sanders to Board of Directors DURHAM, N.C., May 16, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today announced the appointment of Machelle Sanders to the Company’s Board of Directors. Ms. Sanders has served as North Carolina’s Secretary of Commerce since February 2021 and brings strong domain expertise from more than 30 years of operational and quality assurance roles in phar

  • GlobeNewswire

    Fortrea Reports First Quarter 2024 Results

    For the three months ended March 31, 2024, from continuing operations: Revenues of $662.1 millionGAAP net loss of $81.6 millionAdjusted EBITDA of $29.5 millionGAAP and adjusted diluted earnings (loss) per share of $(0.91) and $(0.04), respectivelyBook-to-bill ratio of 1.11x, resulting in >1.2x book-to-bill for the trailing nine monthsPlanned divestiture of assets relating to the Endpoint Clinical and Patient Access businesses on track DURHAM, N.C., May 13, 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasda